Oncomatryx

Developer of antibody-drug conjugates targeting the tumor microenvironment

placeDerio, Basque Country, Spain calendar_todayFounded 2009 groups19 employees language oncomatryx.com

Social engagement

Social engagement: 6.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Ekarpen, BBK.

Investor typeCountShare
Private equity120%
Other / undisclosed480%

Recent activity

30 Jun 2026
Event
I SOLTI-ASEICA Workshop: Antibody-Drug Conjugates (ADCs): Present and Future
26 Jun 2026
Event
Shaping the Future of Cancer Care
23 Jun 2026
Event
BIO International Convention 2026
Coming soon